Pharma Evidence - Real World Data and AI in drug development

Personalised medicine and value-based pricing are becoming increasingly important in drug development. Data is the foundation of both. Clinical studies provide specific data on effect and side-effect of new medicine, but to truly work with personalised medicine and value-based pricing you must draw on a number of other Real World Data sources, such as health registries, apps & wearables data, patient interviews, discrete choice survey etc.

In Pharma Evidence we understand Real World Data and when and how to use them in drug development. We are involved in a number of scientific and commercial projects where Real World Data and Clinical Trial data are combined in innovative ways to provide new possibilities within big data analysis and development of AI to support a faster and better drug development proces.

Pharma Evidence is specialised in identification of data gaps in drug development and in finding and using these data to document value for society and for the individual patient.

Read more about our innovative scientific projects under ‘science’ or be inspired by our commercial products under ‘commercial’.